{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:37Z","timestamp":1747181197345,"version":"3.40.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,7]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Rare tumor-induced osteomalacia (TIO) usually resulted in bone pain, fragility fractures and muscle weakness in clinical, which is caused by the reduced phosphate reabsorption, thus impaired mineralization of the bone matrix and free energy transfer. The specific problems in postsurgical patients are obscure although surgical removal of the tumor is the only definitive treatment. Here, we documented a female TIO patient who suffered more severe bone pain and muscle spasms post-operation. Further, we presented and discussed our explanation for the unexpected symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The main symptoms were whole-body pain and muscle weakness. The patient also presented with osteoporosis and multiple fractures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Elevated serum fibroblast growth factor 23 (FGF23) level and hypophosphatemia indicated the diagnosis of TIO. Positron emission tomography (PET)\/computed tomography (CT) with 68 Ga-DOTATATE located the tumor in the dorsolateral part of the left foot. Histopathological examinations confirmed the diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The tumor was surgically removed immediately after the diagnosis of TIO and localization of the tumor. Postoperatively, calcium carbonate supplement treatment was continued.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Two days after surgery, the serum FGF23 level was decreased to the normal range. Five days after surgery, N-terminal propeptide of type I procollagen and \u03b2-CrossLaps (\u03b2-CTx) had a remarkable increase. A month after surgery, the patient N-terminal propeptide of type I procollagen and \u03b2-CTx levels were decreased obviously, and serum FGF23, phosphate and 24h urinary phosphate were in the normal range.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We report a female patient who presented with osteoporosis and fractures. She was found with an elevation of FGF23 and diagnosis with TIO after PET\/CT scanning. After surgically removing the tumor, the patient experienced more severe bone pain and muscle spasms. Active bone remodeling might be the reason for the symptoms. Further study will reveal the specific mechanism for this abnormal bone metabolism.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034217","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T12:02:01Z","timestamp":1688731321000},"page":"e34217","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3115-2520","authenticated-orcid":false,"given":"Lingfeng","family":"Shi","sequence":"first","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjia","family":"Tang","sequence":"additional","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Duan","sequence":"additional","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Deng","sequence":"additional","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiongyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Endocrinology Department, First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-induced osteomalacia.","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eprac.2022.09.007","article-title":"Phosphatonins: from discovery to therapeutics.","volume":"29","author":"Kritmetapak","year":"2023","journal-title":"Endocr Pract"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","article-title":"Tumor-induced osteomalacia.","volume":"108","author":"Florenzano","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia.","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.","volume":"62","author":"Endo","year":"2015","journal-title":"Endocr J"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature.","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"116064","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (TIO).","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","article-title":"The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.","volume":"64","author":"Feng","year":"2017","journal-title":"Endocr J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance.","volume":"37","author":"Hidaka","year":"2022","journal-title":"J Bone Miner Res"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/endrev\/bnac026","article-title":"Tumor-induced osteomalacia: a comprehensive review.","volume":"44","author":"Minisola","year":"2023","journal-title":"Endocr Rev"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03343720","article-title":"Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.","volume":"23","author":"Huang","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JME-20-0089","article-title":"FGF23-related hypophosphatemic rickets\/osteomalacia: diagnosis and new treatment.","volume":"66","author":"Fukumoto","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/er.2017-00220","article-title":"X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment.","volume":"39","author":"Kinoshita","year":"2018","journal-title":"Endocr Rev"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/RLU.0000000000002290","article-title":"Increased activity due to fractures does not significantly affect the accuracy of 68Ga-DOTATATE PET\/CT in the detection of culprit tumor in the evaluation of tumor-induced osteomalacia.","volume":"43","author":"Ding","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia.","volume":"40","author":"Agrawal","year":"2015","journal-title":"Clin Nucl Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:01:57Z","timestamp":1746324117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":15,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034217","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}